Skip to Content

PAD 0193 (Indomethacin Extended Release 75 mg)

Pill with imprint PAD 0193 is White, Capsule-shape and has been identified as Indomethacin Extended Release 75 mg. It is supplied by Paddock Laboratories, Inc..

Indomethacin is used in the treatment of back pain; bursitis; ankylosing spondylitis; bartter syndrome; cluster headaches and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Indomethacin 75 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for PAD 0193

Indomethacin extended release 75 mg PAD 0193

Indomethacin Extended Release

Imprint
PAD 0193
Strength
75 mg
Color
White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nonsteroidal anti-inflammatory drugs
Pregnancy Category
C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule
Not a controlled drug
Labeler / Supplier
Paddock Laboratories, Inc.
National Drug Code (NDC)
00574-0193
Inactive Ingredients
carboxymethylcellulose sodium, gelatin, lactose monohydrate, microcrystalline cellulose, sodium starch glycolate type A potato, titanium dioxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.